Greg Durham, Contract Specialist

Greg Durham serves as a Contract Specialist within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical research for infectious, immunologic, and allergic disease threats. He manages the full lifecycle of research and development contracts, primarily overseeing complex scientific services related to laboratory infrastructure, biosafety protocols, and medical countermeasure development. His work directly enables NIAID’s strategic response to emerging public health crises by ensuring timely procurement of high-containment research capabilities and diagnostic innovation. Durham’s acquisitions are mission-critical, often involving specialized technical requirements and stringent regulatory compliance in biocontainment environments. Durham maintains a focused relationship with Quality Biological, Inc., a key provider of biological reagents and specialized research materials, and GENOMIC LABS LTD, a partner in advanced genomic analysis services. These vendor partnerships reflect a preference for established, technically proficient contractors with proven expertise in high-complexity life science support. His contracting approach emphasizes reliability, scientific rigor, and adherence to federal biosafety standards, with long-term engagements built on consistent performance and compliance with NIH and CDC guidelines. Durham’s procurement portfolio reflects a strong preference for unrestricted competition, with 100% of awards issued under no set-aside classifications. This pattern underscores a mission-driven emphasis on technical capability over socioeconomic preferences, prioritizing access to the most qualified providers capable of delivering specialized research services under high-containment conditions. While small business participation is not formally targeted, his awards remain open to all qualified vendors meeting stringent scientific and operational criteria. His primary procurement focus is NAICS 541715—Research and Development in the Physical, Engineering, and Life Sciences—encompassing contract research, assay development, pathogen characterization, and laboratory support services. He routinely procures high-specification biosafety level 3 and 4 infrastructure components, diagnostic platform integration, and proprietary biological materials essential for infectious disease research, demonstrating deep domain expertise in life sciences R&D contracting.